NCT02988661.

Trial name or title	Women Empowered to Live With Lupus Study (WELL)
Methods	NRCT
Participants	Inclusion criteria Currently participating in the GOAL study Exclusion criteria Participation in the Chronic Disease Self‐Management Program (CDSMP) in the past five years Significant cognitive impairment
Interventions	Active comparator: Chronic Disease Self‐management Program (CDSMP) A random sample of African American women with SLE selected from the Georgians Organized Against Lupus (GOAL) parent cohort will be used to recruit participants into the CDSMP. This group will be identified as the WELL Cohort. No intervention: usual care African American women consented into the parent Georgians Organized Against Lupus (GOAL) cohort who have not been selected to be enrolled in the intervention will comprise the usual care group. This group will continue their longitudinal assessments as part or the GOAL cohort data collection efforts.
Outcomes	Primary outcomes: Change in Communication with Physicians assessed by the Stanford 3Q Scale Change in Self‐efficacy for Managing Medications assessed by the PROMIS SF8a score Change in Global Health assessed by the PROMIS Global Health score Change in Physical Function assessed by the PROMIS SF10b score Change in Pain Interference assessed by the PROMIS SF8a score Change in Fatigue assessed by the PROMIS SF8a score Change in Sleep Disturbance assessed by the PROMIS SF8a score Change in Anxiety Level assessed by the PROMIS SF8a score Change in Ability to Participate in Social Roles and Activities assessed by the PROMIS SF8a score Secondary outcomes: Change in the Patient Activation Measure (PAM SF 10) score Change in Self‐Efficacy assessed by the PROMIS SF4a score Change in Angry Mood assessed by the PROMIS SF5 score Change in Perceived Stress Scale (PSS) Score Hospitalization Rate Emergency Department Visit Rate
Starting date	January 2017
Contact information	Charmayne M Dunlop‐Thomas, MS, MPH, 404‐251‐8898, cmdunlo@emory.edu
Notes